Unibest
← Back to patent-cliff list

CAS 2180923-64-0

7-(Chloromethyl)-6-(4-chlorophenyl)spiro[3.5]non-6-ene

Codes: (XV)992511-1-a,(XV)992511-1-b

Application context (from source-drug indications)

Chronic lymphocytic leukaemiaLisaftoclaxAcute promyelocytic leukaemiaLisaftoclaxMyelodysplastic syndromeLisaftoclaxAcute myeloid leukaemiaLisaftoclaxDiffuse large B-cell lymphomaLisaftoclaxSystemic lupus erythematosusLisaftoclax

Source drugs (routes using this intermediate)

DrugTierExpiry
LisaftoclaxTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.